REFRACTORY CANCER
Clinical trials for REFRACTORY CANCER explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY CANCER trials appear
Sign up with your email to follow new studies for REFRACTORY CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for hard-to-treat childhood cancers
Disease control CompletedThis early-stage study tested a mix of two drugs (pembrolizumab and decitabine) plus targeted radiation in 22 children and young adults whose solid tumors or lymphoma had returned or stopped responding to treatment. The main goals were to see if the combination was safe and toler…
Matched conditions: REFRACTORY CANCER
Phase: EARLY_PHASE1 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Gene-Guided cancer therapy put to the test in 742 patients
Knowledge-focused CompletedThis study tested whether choosing cancer drugs based on the genetic makeup of a patient's tumor works better than standard treatment. It included 742 adults with advanced solid tumors that had stopped responding to usual therapies. Patients were randomly assigned to receive eith…
Matched conditions: REFRACTORY CANCER
Phase: PHASE2 • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC